thierry dettloff

Life sciences company dedicated to the development of personalized therapies and vaccines. Noria AG presently develops a vaccine based on the mRNA technique against HIV-1. The treatment could be therapeutic and preventive.

Oversaw development of a network of Montessori-inspired childcare centers across France and Belgium. 18 companies, 200 employees. Led financial advisory for the company's listing on Wiener Boerse - Direct Market Plus (Austria). Operations and sales management. Established status of financial condition, framing of opening projects, negotiations with institutional lenders and shareholders, implementation of a continuation plan within receivership.

Young innovative company, working in the field of drugs and peptide synthesis in aqueous media. Nanotracks flagship product: NS637, a water soluble, broad spectrum antifungal drug, presently at pre-clinical stage.

IPO n°1 has been for years the leading French firm in listing French SME's on capital markets. Louis Thannberger has advised more than 400 companies in their listing process, more than any other investment bank in France. Worked closely with Louis, until Louis sadely left us.

• Led strategic partnerships and investor relations for a life sciences company pioneering personalized immune regeneration therapies. • Structured project deal with the objective to raise capital to support the development of personalized vaccines and human monoclonal antibodies. .

• Led strategic initiatives to introduce novel molecular adjuvants for vaccines, addressing market needs and safety concerns.

French call center specializing in sales by telephone (180 employees). Preparation and negotiation of plan for Court. Reorganization of accounting department, implementation of treasury and accounting software (Sage). Human resources management, negotiation with trade unions. Legal restructuring, transfer of assets.

French stock-exchange market and funding fintech platform designed for smaller growing companies. Unique platform across Europe to be both a stock-market and a broker. Development of the platform functionalities. Relations with market and regulatory authorities Corporate Finance adviser assessing SME’s overall appropriateness and suitability for Alternativa market, assisting them throughout the flotation process and helping them to maximize funds raised in the quotation. IPO’s and raise of equity for 40 SMEs.

CFO and Senior advisory engagements. > French industrial group owned by a well-known PE fund (CVC). Financial Advisor. Preparation for disposal of a non core subsidiary. Concluded deal. > Group of 13 hospitals located in the outskirt of Paris owned by a PE fund (Duke Street). Assistance to sale process by the fund (business model, presentation, data room). Concluded deal.

Paris - 3rd largest arena in the world – Financial Advisor on the refurbishment project of the arena. Business model reengineering, preparation of business plan, banks selection and raise of financing (financing of state owned entity in a distressed bank market).. Won the tender offer process against Bouygues and Vinci.